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To study the pathogenesis of lupus nephritis, the cross reactivity between anti-DNA antibody 
and glycosaminoglycans (GAGs) was investigated. :Monoclonal anti-DNA antibodies were obtained 
from hybridomas by the fusion of l\1RL/ Ipr/lpr splenocytes with murine myeloma cells. Some of 
these monoclonal anti-DNA antibodies showed cross reactivity with GAGs, such as hyaluronic acid, 
chondroitin sulfate and heparan sulfate. To elucidate the mechanism of cross reactivity, inhibition 
assays with propanol and polyethylenimine (PEl), a cationic agent, were carried out. Increase of 
the concentration of PEl (0.6 2.0 % vol/vol) resulted in a dose dependent decrease in the binding 
ability of anti-Dl\A antibody to GAGs. Propanol, an organic reagent which disrupts the van der 
Waals bonds between epitopes and paratopes, showed little inhibitory effect on the binding activity 
of monoclonal anti-DNA antibody to GAGs. These results indicate that the binding of anti-DNA 
antibody to GAGs is due to a charge interaction rather than van der Waals forces. Anti-DNA 
antibody which can react with GAGs in the glomerular basement membrane seems to play an 
important role in the pathogenesis of lupus nephritis. 
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High titer of anti-DNA antibody, especiall y anti-
double stranded DNA antibody activity in the sera is 
specifi c for the patients of systemic lupus erythematosus 
(SLE) and correlates with clinical fmdings and severity of 
renal involvement (1). However, the pathogenic signifi-
cance of anti-DNA antibody in lupus nephritis remains 
uncertain. 
There are two proposed mechanisms by which anti-
D A antibody could cause lupus nephriti . One is the 
circulating immune complex (CIC) mechanism: circulat-
ing DNA/ anti-D A antibody immune complex is present 
in the sera of patients with lupus nephritis. However, the 
direct demonstration of D~A both in CIC and glomeruli 
has been d:ifti.cult, and reported only in a few studies (2, 
3). Another mechanism is the in situ IC formation 
mechanism: Izui demonstrated that DNA had a high 
affinity for collagen molecule in GBM in vitro (4). They 
proposed that circulating anti-D:\A antibodies would bind 
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to D:-.JA bound to GBM e:md form the immune complex 
in situ. However, there is a lack of du·ect and concrete 
evidence which supports either of the e two hypotheses. 
Recently, Faaber el al. showed the cross reactivity 
of anti-DNA antibody with GAGs (5, 6), and proposed a 
new hypothe is with re pect to the pathogene is of lupus 
nephritis. They suggest that anti-DNA antibody binds 
directly to the GAGs to form the immune complex in ·itu 
and causes lupus nephritis. 
We cultivated the monoclonal <:mti-D A antibodies 
and studied the cross reactiyjty with GAGs to investigate 
the preci e mechanism of thi · cross reactivity. 
Materials and Methods 
,\1ice. l\lRL-lpr/ lpr mice W<'n' purcha~Pd from Ki\\"a labora-
tory, Japan and Bi\LB/ C mice were obtained from the animal 
colony of our ins titute. 
Cell fusion and cloning. Somatic cell hybridization was carried 
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out as discribcd by Kohler and :YrilstC'in (7). Spleen cells from 
MRL-Ipr/ lpr mice were fused with the non-immunoglobulin secret-
ing aminopterin sensitive murine myeloma cell line. ~S 1. Anti-
DNA antibody-producing hybridomas were cloned by repeating the 
procedure of limiting dilutions. 
DNA and glycosamirwf5lycan~. Calf thymus D 'A, pur-
chased from Worthington Biochemical Corporation, ew Jersey, 
CSA, was dissolved in 0.01 :vi Tris-ITCI buffer, pll8.0containing 
0.001 M I ~ DT/\. Chondroitin sulfate and hyalulonic acid were 
obtainncd from Sigma Chemical Company, St. Louis, Missouri, 
USA lleparan sulfall' was obtained from Scikagaku Kogyo, 
Tokyo, .Japan. Tlwsc GAGs were dissol ved in phosphate buffered 
saline (PBS), pl l 7.4. 
l~nzymc- link('d immwwsorbcnl assay. Anti- D A and anti-
c; AG antibody assays wer<' perform(•d by rnzyme-linked im-
munosorbent assay (ELISA). Each well of polystyrene microtiter 
plate ISumitomo, Tokyo, .Japan) was precoatrd with lOOJ.ll of 
0.75 mg/ ml of prolamine sulfat<' and incubated overnight at 4 C. 
After washing with PBS, lOOJ.l l/wcll of DNA (200,ug/ ml) or 
GAG (500,ug/ ml ) were adckd to each well and incubated overnight 
at 4 C. Thl' plat(•s wcrc washed three times with PBS to remove 
excess <mtigcn. Unbound sites on the plates were subsequcnLiy 
hlockcd for 1 h at room tl'm prature with 1 % ( wt/ vol) bovine 
surum albumin (13Si\ ) in PBS cmd then washed three times with 
PHS. One hundrC'd ,u I of a monoclonal antibody to be tested was 
added to each well and incubated for 1 h at room temprrature. 
After washing three t[mes with Pf3S, 100 ,u I of peroxidase-
conjugal ·d goat <mti-mousl' !gG (Cappel, Pcnn~ylv;mia, USA), 
diluted 1: 3,000 in PBS containing ] % BSA werC' added and 
incubated again for 1 h at room tempcratur·e. Then 100,u l of 
~ubstrate solution, 1 rng/ ml o-phcnylencdicullinc (W ako Pure 
Clwmic;u Industries, Tokyo, Japan) dissolved in 0.1 M citrate 
buffer. pH 5.0. containing 1 ,u 1/ ml of 35 % ( vol/ vol) ll20 2 was 
added to each well. After 10 min , the reaction was stopped by 
adding 50 ,u I of 3 I ICI. Thr optical absorbance was measured at 
492 nm by <m ETA RE1\DER 810-RAD MODEL 2550. 
Crithidia assay. Crithidia assay was carried out to verify 
anti-double ,;trandcd DNA activity. Crithid ia luci llae was plated on 
glass slick . .\lonoclomu antibodies were placed on the slides c:md 
F lTC-cnnjugated goat anti-mouse lgG antibodies 1\Wl' applied. 
F luorescence of kinetoplasts was obst>rVl'cl h~· immunofluorescent 
microscop~. 
ELIS1\ u•ith dij{erent salt concentration. To irn·estigate the 
influence of ionic strength on the interaction of monoclonal anti-
bodies and D A or GAGs, ELISAs ll'ere performed with \'ru·iou · 
concentrations of aCI. l\lonodonal w1ti-D lJ\ antibodies were 
appliecl to th(• antigC'n-coatt•d wells in the presence nf different 0JaCI 
wncentrations (0.03 1!\I). 
Inhibition studies. To elucidate the mechanism of interactions 
between cmti-D TA antibodies and ])~ ,\ or G.\ Gs. El JSA wC're 
performed in the presence of a cationic agent. PEI or prop<mol. 
1onoclonal antibodies 11·ere appied to ;mtigen-coated \\'ells in tllC' 
presence of increasing concentration of PEl \0.03 1 % \'OI 1·ol) or 
propcmol (0.03 4.00% \'OI \on. The following procedw-es 1\'CI'e 
performed under standard conditions. As a control study, the 
scm1e inhibition studies were performed using tll)Toid microsomal 
antigen and monoclonal anti-microsomal antibody, which were 
produced in our laboratory (8). 
Results 
Production of monoclonal anti-DNA antibodies. The 
cell-fusion procedure was carried out twice and yielded 98 
cell lines producing anti-DNA antibody. 
Cross-react·ivity of monoclonal anti-DNA antibodies 
with GAGs. Seven clones of anti-DNA antibody produc-
ing hybridomas were able to cross-react with GAGs 
(Table 1). Anti-DNA antibody activity of these clones 
was also conftrmed with Crithidia assay. There was a 
correlation between anti-DNA activity and anti-GAG 
activity in these monoclonal antibodies (Figs. 1, 2) 
Irifluence of the salt concentration on the binding of 
monoclonal anti-DNA antibodies to DNA and GAG. 
Decrease of binding activity to DNA and GAG in the 
presence of increasing concentration of NaCl in a dose-
dependent manner was demonstrated (Fig. 3). These 
data indicate that bindings of these monoclonal antibodies 
to D A and GAGs were not mediated \-vith non-specific 
charge interation because binding activities were not 
signiflc;mtly reduced with 0.3 M NaCI in which concentra-
tion, non-speciftc charge interaction was inhibited (9). It 
was also demonstrated that aCl at the concentrations 
used in this study did not dissociate the DNA or GAG 
from the plate (Data was not shown). 
Effect of PEl on the binding to DNA and GAG. 
The presence of increasing amount of PEI caused dose-
Table 1 Binding ac tivrty of monoclonal <mti-Dr\r\ antibodies to 
glycosaminogl; ran' 
Antigen 
llybr·icloma 
r· lorw' llcpanm Chondroitin IJ1·alulonic D~ . ..\ 
sulfate sulfate acid 
lG3 0.599 0.413 0.609 0.409 
L\9 1.273 1.820 1.523 1.667 
3G2 0.380 0.3~8 0.351 0.647 
.3Bl 1.033 1.1 -14 1.096 1.015 
389 1.778 1.092 1.351 1.746 
9C-l 0..128 0.905 0. 9~ 1.989 
7C1 0.759 1.664 0.326 1.345 
.\II ,-a] ups represent optical ab,orbance at 492 nm. 
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Fig. 3 lnOuence of inonic strength on the binding actil' itie. of monoclonal 
anti-Dt-.;A m1tibody (li\9 clone) to D\'A <md glyco <uni noglycan . Binding of 
monoclonal <mtibocly to D:\ A ( ~ ) and hcparan sulfate ( • • ). 
dependent reduction in anti-D A and anti-GAG activity 
(Fig. 4). Five % (vol/ vol ) of PEI reduced anti-DNA 
activity and anti-GAG activity by 50 % and 65 %, 
respectively. But PEI did not show an inhibitory effect on 
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Fig. 4 Lnnucncc of polyPUl) lenimine on tlw binding of monoclonal 
anti hodiP!-. to D~/\. gi)Co~aminoglycan cUld Ul)Toid rnirro,omal <mtigen . 
Binding of monoclonal anti-0:'\/\ antibody (l /\9 dum• to]);'\,\ r ) <mel 
heparan sui fall' ( • • ). Bmcling of monoclon<J anti- mitTU!-.O tmJ antibody tu 
tl1yroirl micro!-.Olll<J ;mtigl>n • • ). 
the other antigen-antibody interaction; microsomal anti-
gen and monoclonal anti-microsomal antibody. 
Effect o.f propanol on the binding to DNA and GAG. 
Propanol is an organic agent which inhibit van der Waals 
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force between antigen and antibody (10, 11). As shown 
in Fig. 5, increase of prop<mol concentration had little 
effect on the binding activity of monoclonal antibodies to 
D A and GAG_ On the other hand, the binding activity 
of monoclonal anti-microsomal antibody to microsomal 
antigen was inhibited by propanol. 
Discus ion 
Anti-D A antibody has been believed to play an 
important role in the pathogenesis of systemic lupus 
erythematosus ( I .. E)_ But the mechanism that involves 
anti-D A antibody that cause, tissue injurie has not 
been elu cidated. Development of monoclonal <mti-Dl A 
antibodic - by somatic cell hybridization techniques has 
facilitated the analysis of the character of ;mti-D_ A 
· antibody and its target antigen. 
Studies us ing monoclonal anti-D A antibody re,·ealed 
that anti-D A antibody could react to a broad spectrum 
of antigens including those with molecular structures that 
were apparently different from D A. Cross-reacti,·ity 
with the synthetic polynuclcotides of different compo,- ilion 
ha. been reported. The cross-reactive <:mtigcnic determi-
nant seemed to be in the ugar-phosphate backbone (12). 
Anti-DNA antibody were able to react with cardiolipin 
and phospholipids. Phosphodiester linked pho phate 
groups were identified as possible cross-reactive moieties 
(13 15). Furthermore, cross-reactivity of anti-D A anti-
body extended to a variety of antigens, such as IgG, 
platelet, Raji cell and endogenous bacteria (16 18). 
F aaber el al. also . reported the cross-reactivity with 
GAGs (5, 6). The wide variety of cross-reactions is 
diffJcult to explain with the existing data. This situation 
seems rich in possibilities for further investigations. 
The repulsive and attractive forces that constitute the 
non-covalent interaction between antigens and antibodies 
(10) are charactrerized by a) Dispersion (van der Waals) 
force and b) E lectrostatic (Coulombic) interaction. The 
organic reagents, propanol and acetic acid, decrease the 
surface tension of the liquid medium and disrupt the van 
der Waals bond to dissociate the antigen-antibody com-
plex. 1icrosomal antigen and anti-microsomal antibody 
complex is eff1ciently dissociated by propanol. However, 
the bindings of monoclonal anti-DNA antibodies to DNA 
and GAG were not inhibited by propanol at the concentra-
tion in which microsomal antigen and anti-microsomal 
antibody was dissociated. From these date, it may be 
concluded that van der Waals force does not contribute 
the interaction between anti-Dl A antibody and DNA or 
GAG. 
Both D\TA and GAG are negatively charged. Ebling 
;mel Halm reported that anti-D. A antiboilies eluted from 
NZB/ W F1 mouse kidneys had higher isoclectric points 
than those in the sera. They speculated that cationic 
anti-D A antibodies were pathogenic in lupus neplu·itis 
(19). In the present study, the cationic agent, PEl, 
inhibited the binding of anti-DNA antibody to DKA and 
GAG. It is pos ible that the binding of anti-D A anti-
body to GAG is mediated by simple charge-charge inter-
action. Because the 0.3 M ionic strength, which can 
prevent non-specif1c charge-charge interaction ilid not 
affect the interaction between anti-DNA antibody and 
GAG. this interaction does not seem to be mediated with 
a simple force between opposite charges. From these 
re, ult , it appear that this charge-charge interaction 
exists between epitope and paratope. 
Van der Waals force decreases at a rate inverse to the 
7th power of the intermolecular distance. The distance 
between two molecules should be very close for van der 
\Vaals force to work efficiently. On tl1e other hand, 
electrostatic force is inversely proportional to the second 
power of the intermolecular distance and could work at 
distances where van der Waals force could not work. 
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There wa a significant correlation between anti-D1 t\ 
activity and anti-GAG activity in these monoclonal <:mti-
bodies. However, D A and GAG do not hm·c similar 
molecular structures other than repeating negative charged 
residues. It seems to be reasonable that vcu1 der Waals 
force does not work effectively between such molecules. 
In this study, the cro s-reactivity of monoclonal CU1ti-
D A antibody with GAG was demonstrated under 
vcu·ious conditions. Hepcu·an sulfate proteoglycan, which 
is one of the GAGs in glomeruli, is an important compo-
nent of anionic site in the GBM and necesscu·y to maintain 
both charge and size selective bcuTiers (20, 21). The 
cross-reaction betvveen anti-D A antibody with GAG 
may play two possible roles in the pathogenesis of lupus 
nephritis. Direct binding of anti-D A cu1tibody to GAG 
may lead to the formation of the immune complex in situ 
and cause the activation of complements and tis ue 
damage. Another possibility is that anti-D A cu1tibody 
may neutralize the negative chcu·ge of GBM to disturb the 
chcu·ge selective barrier and result in proteinuria. 
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